STOCKHOLDER ALERT: Monteverde & Associates Continues to Investigate the Following Merger

NEW YORK, Nov. 6, 2020 /PRNewswire/ --

Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating:

• Watford Holdings, Ltd. (WTRE) relating to its proposed acquisition by Arch Capital Group, Ltd. Under the terms of the agreement, Watford shareholders will receive $31.10 per share in cash. Click here for more information: http://monteverdelaw.com/case/watford-holdings-ltd. It is free and there is no cost or obligation to you.
  
  
• Perceptron, Inc. (PRCP) relating to its proposed acquisition by Atlas Copco North America, LLC. Under the terms of the agreement, Perceptron shareholders will receive $7.00 per share in cash. Click here for more information: http://monteverdelaw.com/case/perceptron-inc. It is free and there is no cost or obligation to you.
  
  
• Inphi Corporation (IPHI) relating to its proposed merger with Marvell Technology Group Ltd. Under the terms of the agreement, IPHI shareholders will receive $66.00 in cash and 2.323 shares of stock of the newly-combined company for each share that they own. Click here for more information: https://www.monteverdelaw.com/case/inphi-corporation. It is free and there is no cost or obligation to you.
  
  
• Xilinx, Inc. (XLNX) relating to its proposed sale to Advanced Micro Devices, Inc. Under the terms of the agreement, XLNX shareholders will receive 1.7234 shares of AMD common stock for each share they own. Click here for more information: https://www.monteverdelaw.com/case/xilinx-inc. It is free and there is no cost or obligation to you.
  
  
• Cleveland BioLabs, Inc. (CBLI) relating to the creation of a combined company between the Company and Cytocom, Inc. ("Cytocom"). Under the terms of the agreement, BioLabs shareholders are expected to own only 39% control of the combined company, with Cyctom shareholders expected to own 61%. Click here for more information: https://www.monteverdelaw.com/case/cleveland-biolabs-inc. It is free and there is no cost or obligation to you.

About Monteverde & Associates PC

We are a national class action securities litigation law firm that has recovered millions of dollars and is committed to protecting shareholders from corporate wrongdoing.  Our lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions.  Mr. Monteverde is recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019, an award given to less than 2.5% of attorneys in a particular field.  He has also been selected by Martindale-Hubbell as a 2017-2019 Top Rated Lawyer.  Our firm's recent successes include changing the law in a significant victory that lowered the standard of liability under Section 14(e) of the Exchange Act in the Ninth Circuit. Thereafter, our firm successfully preserved this victory by obtaining dismissal of a writ of certiorari as improvidently granted at the United States Supreme Court. Emulex Corp. v. Varjabedian, 139 S. Ct. 1407 (2019).  Also, in 2019 we recovered or secured six cash common funds for shareholders in mergers & acquisitions class action cases.

If you own common stock in any of the above listed companies and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.

Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341

Attorney Advertising. (C) 2020 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com).  Prior results do not guarantee a similar outcome with respect to any future matter.

SOURCE Monteverde & Associates PC